| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/15/2009 | CN101406656A Medicament for treating hepatic cirrhosis with hypoproteinemia after hepatitis |
| 04/15/2009 | CN101406654A Oral liquid for treating hoove |
| 04/15/2009 | CN101406643A Chinese medicine micro powder granule for treating appendicitis |
| 04/15/2009 | CN101406640A Citron suspension |
| 04/15/2009 | CN101406629A Buccal tablets for treating painful swelling of gingiva and preparation method thereof |
| 04/15/2009 | CN101406623A Health-care wine for males |
| 04/15/2009 | CN101406601A Chinese medicine for treating mouth ulcer and gastric ulcer |
| 04/15/2009 | CN101406599A Pharmaceutical composition for treating chronic atrophic gastritis |
| 04/15/2009 | CN101406597A Pure natural Chinese herbal medicine health products |
| 04/15/2009 | CN101406573A Health-care product with toxin-expelling and health-preserving efficacy |
| 04/15/2009 | CN101406572A Spray for removing peculiar smell in oral cavity |
| 04/15/2009 | CN101406567A Medicament for oral cavity for treating dentalgia |
| 04/15/2009 | CN101406554A Kuaiyi granule |
| 04/15/2009 | CN101406520A San wu shen jia capsule |
| 04/15/2009 | CN101406516A Pure medicinal formulation for treating hepatopathy |
| 04/15/2009 | CN101406491A Oil-in-water Cordyceps sinensis emulsion and preparation technique |
| 04/15/2009 | CN101406489A Micro-ecological complex bacterial agent and method of preparing micro-ecological complex bacterial agent |
| 04/15/2009 | CN101406486A Method for preparing maggot health-care oral liquid |
| 04/15/2009 | CN101406485A Method for producing decoction for quickly relieving bowels |
| 04/15/2009 | CN101406484A Chinese medicine for promoting digestion |
| 04/15/2009 | CN101406465A Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 04/15/2009 | CN101406462A Domperidone orally disintegrating tablets as well as preparation method and quality control method thereof |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478349C Nucleoside fluoride compound, its production and use |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478026C Delivery system for biological component |
| 04/15/2009 | CN100478017C Cathartic medicine composition |
| 04/15/2009 | CN100478016C Sarcandra solid dispersion and its preparing method |
| 04/15/2009 | CN100478006C Chinese traditional medicine preparation for treating acute or chronic hepatitis |
| 04/15/2009 | CN100477999C Dispersible tablet of colloid petcin |
| 04/15/2009 | CN100477996C Extract of star of bethlehem and its prepn process, medicinal composition and use |
| 04/15/2009 | CN100477992C Substituted piperazine and piperidine calcium channel blockers |
| 04/15/2009 | CN100477987C Method for preparing sea cucumber active agent soft capsule |
| 04/14/2009 | US7517996 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517686 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/14/2009 | US7517681 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 04/14/2009 | US7517661 Methods of screening for ligands for FPRL2 |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | CA2417050C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2386190C Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/14/2009 | CA2362914C Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
| 04/14/2009 | CA2253211C Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
| 04/14/2009 | CA2237582C Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 04/09/2009 | WO2009045313A2 Oxypiperidine derivatives as histamine receptor antagonists |
| 04/09/2009 | WO2009045123A1 Medicinal agent exhibiting hemopoiesis-stimulating and hepatoprotective actions |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044548A1 Antidiarrhetic composition, product containing the same and method of preventing diarrhea |
| 04/09/2009 | WO2009044439A1 Composition for preventing or treating liver disease |
| 04/09/2009 | WO2009043856A2 Modulation of tissue fatty acid composition of a host by human gut bacteria |
| 04/09/2009 | WO2009043518A2 Use of a combination of cart peptides as a therapeutic agent |
| 04/09/2009 | WO2009043176A1 Herbal compositions and methods for treating hepatic disorders |
| 04/09/2009 | WO2009043134A1 Mouthwash and method of using same for the treatment of mucositis or stomatitis |
| 04/09/2009 | WO2009043093A1 Hif inhibition |
| 04/09/2009 | WO2009021868A3 Novel piperazine amide derivatives |
| 04/09/2009 | WO2008151927A3 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 04/09/2009 | WO2008149163A3 Potassium ion channel modulators and uses thereof |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093545 Phenoxyalkycarboxylic acid derivatives in the treatment of irritable bowel syndrome or ulcerative colitis |
| 04/09/2009 | US20090093522 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 04/09/2009 | US20090093519 Methods and Compositions to Inhibit Edema Factor and Adenylyl Cyclase |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093476 Pyrrolo[1,2-a]quinoxaline derivatives as adenosine a3 receptor modulators and uses thereof |
| 04/09/2009 | US20090093473 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090092658 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 04/09/2009 | US20090092643 Foam Strip for the Delivery of Oral Care Compositions |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092590 Method for improving stool characteristics in infants |
| 04/09/2009 | US20090092586 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype |
| 04/09/2009 | US20090092585 Treating diarrhea in dogs |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092543 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 04/09/2009 | DE4021517B4 Formulierungen mit verlangsamter Freisetzung wasserlöslicher Peptide Formulations with delayed release of water-soluble peptides |
| 04/09/2009 | CA2734139A1 Antibody therapy for use in the digestive tract |
| 04/09/2009 | CA2710406A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2701583A1 Mouthwash and method of using same for the treatment of mucositis or stomatitis |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701190A1 Herbal compositions and methods for treating hepatic disorders |
| 04/09/2009 | CA2700963A1 Oxypiperidine derivatives and methods of use thereof |
| 04/08/2009 | EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/08/2009 | EP2044957A1 Treatment agent for inflammatory bowel disease |
| 04/08/2009 | EP2044945A1 Immunomodulating agent |
| 04/08/2009 | EP2044939A1 Therapeutic agent for liver fibrosis |
| 04/08/2009 | EP2043678A2 Caspase-8 and inflammation, infection and wound healing |
| 04/08/2009 | EP2043670A1 Fermented plant extracts, methods of production and uses |
| 04/08/2009 | EP2043669A2 Compositions and methods for treating and preventing gastro esophageal reflux disease |